Wearable technology for the selective detection and continuous monitoring of movement disorders related to Parkinson’s disease

Project Information

PD-Watch

Grant agreement ID: 876156

DOI

10.3030/876156

Project closed

EC signature date 31 July 2019

Start date 1 August 2019

End date 31 January 2020

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

BIOMEDICAL LAB S.R.L.
Italy

Periodic Reporting for period 1 - PD-Watch (Wearable technology for the selective detection and continuous monitoring of movement disorders related to Parkinson’s disease)

Reporting period: 2019-08-01 to 2020-01-31

Summary of the context and overall objectives of the project

The clinical diagnosis and time course assessment of Parkinson’s disease (PD) are based on performing neurological examinations and simple motor tests. However, these only assess the PD patient’s health status limited to the duration of the testing, and thus fail to detect fluctuations in motor symptoms, which can vary considerably from one day to the next. In order to reduce this discrepancy, Biomedical Lab has developed the PD-Watch, which is a wearable device, configured as a wristwatch, for continuous and long-term monitoring of movement disorders. The value proposition of the PD-Watch is to provide a powerful tool and an innovative solution to identify the best possible treatment specific to each patient that will minimise PD movement disorders. The PD-Watch has an improved ability to discriminate neurological originating motor activity from daily regular patient actions and movements. The PD-Watch has already been tested during a preliminary clinical trial and is protected from an intellectual property standpoint.
The feasibility study aims to achieve an in-depth evaluation on the identification of appropriate approaches and elements for allowing a decision on the how to progress with a course of action.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

Main work perfomed includes especially technical tests in order to define the device’s technical configuration, improvements in freedom to operate condition, better knowledge about competitors.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The value proposition of the PD-Watch is to provide a powerful tool and an innovative solution to identify the best possible treatment specific to each patient that will minimise PD movement disorders.

PD-Watch project image